PMC:7321036 / 110114-111390
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T35 | 82-86 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T36 | 383-387 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T389 | 838-847 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T74 | 68-78 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T75 | 82-91 | http://purl.obolibrary.org/obo/CLO_0000031 | denotes | cell line |
T76 | 108-109 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T77 | 153-157 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T78 | 179-180 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T79 | 383-387 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T80 | 450-460 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T81 | 496-497 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T82 | 523-531 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T83 | 748-756 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T84 | 781-785 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T85 | 960-968 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T31298 | 309-313 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T55659 | 326-339 | Chemical | denotes | chlorzoxazone | http://purl.obolibrary.org/obo/CHEBI_3655 |
T66943 | 341-351 | Chemical | denotes | paclitaxel | http://purl.obolibrary.org/obo/CHEBI_45863 |
T86581 | 354-364 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T22512 | 1146-1150 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 61-78 | http://purl.obolibrary.org/obo/GO_0016301 | denotes | kinase activities |
T26 | 383-393 | http://purl.obolibrary.org/obo/GO_0007049 | denotes | cell cycle |
T27 | 443-460 | http://purl.obolibrary.org/obo/GO_0016301 | denotes | kinase activities |
T28 | 953-968 | http://purl.obolibrary.org/obo/GO_0016301 | denotes | kinase activity |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2351 | 326-339 | Chemical | denotes | chlorzoxazone | MESH:D002753 |
2352 | 341-351 | Chemical | denotes | paclitaxel | MESH:D017239 |
2353 | 838-847 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T940 | 0-422 | Sentence | denotes | In addition to the time-course experiment, we also estimated kinase activities of cell line perturbation in a range of biological conditions using the K-test based approach, from a large resource of previously published phosphoproteomics datasets comprising of 435 biological conditions which include several drug treatments (chlorzoxazone, paclitaxel), inhibitors (EGFRi, AKTi) and cell cycle states (Ochoa et al., 2016). |
T941 | 423-656 | Sentence | denotes | After selecting for kinase activities derived from 3 or more substrates, a total of 214 kinases had activity estimates for at least one biological condition including all 97 kinases which were estimated in the time-course experiment. |
T942 | 657-807 | Sentence | denotes | Of the 435 conditions, 309 conditions with at least one kinase with significantly changing activity (-log10(p value) from Z-test > 2.5) were selected. |
T943 | 808-978 | Sentence | denotes | Individual time points of the infection experiment were correlated with each selected biological condition based on Pearson correlation of their kinase activity profiles. |
T944 | 979-1073 | Sentence | denotes | Conditions with significant correlation (5% FDR) with one or more time points were identified. |
T945 | 1074-1193 | Sentence | denotes | Several conditions corresponded to the same biological treatment (i.e., drug perturbation) in different concentrations. |
T946 | 1194-1276 | Sentence | denotes | In such cases, the conditions are represented together with strongest correlation. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32645325-27909043-20773121 | 416-420 | 27909043 | denotes | 2016 |